Category Archives: DNA

LOS ANGELES, United States: The report is an all-inclusive research study of the global DNA and RNA Extraction Kit market taking into account the growth factors, recent trends, developments, opportunities, and competitive landscape. The market analysts and researchers have done extensive analysis of the global DNA and RNA Extraction Kit market with the help of research methodologies such as PESTLE and Porters Five Forces analysis. They have provided accurate and reliable market data and useful recommendations with an aim to help the players gain an insight into the overall present and future market scenario. The DNA and RNA Extraction Kit report comprises in-depth study of the potential segments including product type, application, and end user and their contribution to the overall market size.

Get PDF Sample Copy of Report: (Including TOC, List of Tables & Figures, Chart) https://www.qyresearch.com/sample-form/form/1518859/global-dna-and-rna-extraction-kit-market

In addition, market revenues based on region and country are provided in the DNA and RNA Extraction Kit report. The authors of the report have also shed light on the common business tactics adopted by players. The leading players of the global DNA and RNA Extraction Kit market and their complete profiles are included in the report. Besides that, investment opportunities, recommendations, and trends that are trending at present in the global DNA and RNA Extraction Kit market are mapped by the report. With the help of this report, the key players of the global DNA and RNA Extraction Kit market will be able to make sound decisions and plan their strategies accordingly to stay ahead of the curve.

Competitive landscape is a critical aspect every key player needs to be familiar with. The report throws light on the competitive scenario of the global DNA and RNA Extraction Kit market to know the competition at both the domestic and global levels. Market experts have also offered the outline of every leading player of the global DNA and RNA Extraction Kit market, considering the key aspects such as areas of operation, production, and product portfolio. Additionally, companies in the report are studied based on the key factors such as company size, market share, market growth, revenue, production volume, and profits.

Key Players Mentioned in the Global DNA and RNA Extraction Kit Market Research Report: Qiagen, Thermo Fisher Scientific, Merck KGaA, Roche, Cytiva, Agilent, Danaher, Promega, Bio-Rad, Bioneer, Akonni Biosystems

Global DNA and RNA Extraction Kit Market Segmentation by Product: DNA Extraction KitsRNA Extraction Kits

Global DNA and RNA Extraction Kit Market Segmentation by Application: HospitalLaboratoryOther

The DNA and RNA Extraction Kit Market report has been segregated based on distinct categories, such as product type, application, end user, and region. Each and every segment is evaluated on the basis of CAGR, share, and growth potential. In the regional analysis, the report highlights the prospective region, which is estimated to generate opportunities in the global DNA and RNA Extraction Kit market in the forthcoming years. This segmental analysis will surely turn out to be a useful tool for the readers, stakeholders, and market participants to get a complete picture of the global DNA and RNA Extraction Kit market and its potential to grow in the years to come.

Key questions answered in the report:

Request for customization in Report: https://www.qyresearch.com/customize-request/form/1518859/global-dna-and-rna-extraction-kit-market

Table of Contents:

1 DNA and RNA Extraction Kit Market Overview1.1 DNA and RNA Extraction Kit Product Overview1.2 DNA and RNA Extraction Kit Market Segment by Type1.2.1 DNA Extraction Kits1.2.2 RNA Extraction Kits1.3 Global DNA and RNA Extraction Kit Market Size by Type (2015-2026)1.3.1 Global DNA and RNA Extraction Kit Market Size Overview by Type (2015-2026)1.3.2 Global DNA and RNA Extraction Kit Historic Market Size Review by Type (2015-2020)1.3.2.1 Global DNA and RNA Extraction Kit Sales Market Share Breakdown by Type (2015-2026)1.3.2.2 Global DNA and RNA Extraction Kit Revenue Market Share Breakdown by Type (2015-2026)1.3.2.3 Global DNA and RNA Extraction Kit Average Selling Price (ASP) by Type (2015-2026)1.3.3 Global DNA and RNA Extraction Kit Market Size Forecast by Type (2021-2026)1.3.3.1 Global DNA and RNA Extraction Kit Sales Market Share Breakdown by Application (2021-2026)1.3.3.2 Global DNA and RNA Extraction Kit Revenue Market Share Breakdown by Application (2021-2026)1.3.3.3 Global DNA and RNA Extraction Kit Average Selling Price (ASP) by Application (2021-2026)1.4 Key Regions Market Size Segment by Type (2015-2020)1.4.1 North America DNA and RNA Extraction Kit Sales Breakdown by Type (2015-2026)1.4.2 Europe DNA and RNA Extraction Kit Sales Breakdown by Type (2015-2026)1.4.3 Asia-Pacific DNA and RNA Extraction Kit Sales Breakdown by Type (2015-2026)1.4.4 Latin America DNA and RNA Extraction Kit Sales Breakdown by Type (2015-2026)1.4.5 Middle East and Africa DNA and RNA Extraction Kit Sales Breakdown by Type (2015-2026)

2 Global DNA and RNA Extraction Kit Market Competition by Company2.1 Global Top Players by DNA and RNA Extraction Kit Sales (2015-2020)2.2 Global Top Players by DNA and RNA Extraction Kit Revenue (2015-2020)2.3 Global Top Players DNA and RNA Extraction Kit Average Selling Price (ASP) (2015-2020)2.4 Global Top Manufacturers DNA and RNA Extraction Kit Manufacturing Base Distribution, Sales Area, Product Type2.5 DNA and RNA Extraction Kit Market Competitive Situation and Trends2.5.1 DNA and RNA Extraction Kit Market Concentration Rate (2015-2020)2.5.2 Global 5 and 10 Largest Manufacturers by DNA and RNA Extraction Kit Sales and Revenue in 20192.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in DNA and RNA Extraction Kit as of 2019)2.7 Date of Key Manufacturers Enter into DNA and RNA Extraction Kit Market2.8 Key Manufacturers DNA and RNA Extraction Kit Product Offered2.9 Mergers & Acquisitions, Expansion

3 Global DNA and RNA Extraction Kit Status and Outlook by Region (2015-2026)3.1 Global DNA and RNA Extraction Kit Market Size and CAGR by Region: 2015 VS 2020 VS 20263.2 Global DNA and RNA Extraction Kit Market Size Market Share by Region (2015-2020)3.2.1 Global DNA and RNA Extraction Kit Sales Market Share by Region (2015-2020)3.2.2 Global DNA and RNA Extraction Kit Revenue Market Share by Region (2015-2020)3.2.3 Global DNA and RNA Extraction Kit Sales, Revenue, Price and Gross Margin (2015-2020)3.3 Global DNA and RNA Extraction Kit Market Size Market Share by Region (2021-2026)3.3.1 Global DNA and RNA Extraction Kit Sales Market Share by Region (2021-2026)3.3.2 Global DNA and RNA Extraction Kit Revenue Market Share by Region (2021-2026)3.3.3 Global DNA and RNA Extraction Kit Sales, Revenue, Price and Gross Margin (2021-2026)3.4 North America DNA and RNA Extraction Kit Market Size YoY Growth (2015-2026)3.4.1 North America DNA and RNA Extraction Kit Revenue YoY Growth (2015-2026)3.4.2 North America DNA and RNA Extraction Kit Sales YoY Growth (2015-2026)3.5 Asia-Pacific DNA and RNA Extraction Kit Market Size YoY Growth (2015-2026)3.5.1 Asia-Pacific DNA and RNA Extraction Kit Revenue YoY Growth (2015-2026)3.5.2 Asia-Pacific DNA and RNA Extraction Kit Sales YoY Growth (2015-2026)3.6 Europe DNA and RNA Extraction Kit Market Size YoY Growth (2015-2026)3.6.1 Europe DNA and RNA Extraction Kit Revenue YoY Growth (2015-2026)3.6.2 Europe DNA and RNA Extraction Kit Sales YoY Growth (2015-2026)3.7 Latin America DNA and RNA Extraction Kit Market Size YoY Growth (2015-2026)3.7.1 Latin America DNA and RNA Extraction Kit Revenue YoY Growth (2015-2026)3.7.2 Latin America DNA and RNA Extraction Kit Sales YoY Growth (2015-2026)3.8 Middle East and Africa DNA and RNA Extraction Kit Market Size YoY Growth (2015-2026)3.8.1 Middle East and Africa DNA and RNA Extraction Kit Revenue YoY Growth (2015-2026)3.8.2 Middle East and Africa DNA and RNA Extraction Kit Sales YoY Growth (2015-2026)

4 Global DNA and RNA Extraction Kit by Application4.1 DNA and RNA Extraction Kit Segment by Application4.1.1 Hospital4.1.2 Laboratory4.1.3 Other4.2 Global DNA and RNA Extraction Kit Sales by Application: 2015 VS 2020 VS 20264.3 Global DNA and RNA Extraction Kit Historic Sales by Application (2015-2020)4.4 Global DNA and RNA Extraction Kit Forecasted Sales by Application (2021-2026)4.5 Key Regions DNA and RNA Extraction Kit Market Size by Application4.5.1 North America DNA and RNA Extraction Kit by Application4.5.2 Europe DNA and RNA Extraction Kit by Application4.5.3 Asia-Pacific DNA and RNA Extraction Kit by Application4.5.4 Latin America DNA and RNA Extraction Kit by Application4.5.5 Middle East and Africa DNA and RNA Extraction Kit by Application5 North America DNA and RNA Extraction Kit Market Size by Country (2015-2026)5.1 North America Market Size Market Share by Country (2015-2020)5.1.1 North America DNA and RNA Extraction Kit Sales Market Share by Country (2015-2020)5.1.2 North America DNA and RNA Extraction Kit Revenue Market Share by Country (2015-2020)5.2 North America Market Size Market Share by Country (2021-2026)5.2.1 North America DNA and RNA Extraction Kit Sales Market Share by Country (2021-2026)5.2.2 North America DNA and RNA Extraction Kit Revenue Market Share by Country (2021-2026)5.3 North America Market Size YoY Growth by Country5.3.1 U.S. DNA and RNA Extraction Kit Market Size YoY Growth (2015-2026)5.3.2 Canada DNA and RNA Extraction Kit Market Size YoY Growth (2015-2026)6 Europe DNA and RNA Extraction Kit Market Size by Country (2015-2026)6.1 Europe Market Size Market Share by Country (2015-2020)6.1.1 Europe DNA and RNA Extraction Kit Sales Market Share by Country (2015-2020)6.1.2 Europe DNA and RNA Extraction Kit Revenue Market Share by Country (2015-2020)6.2 Europe Market Size Market Share by Country (2021-2026)6.2.1 Europe DNA and RNA Extraction Kit Sales Market Share by Country (2021-2026)6.2.2 Europe DNA and RNA Extraction Kit Revenue Market Share by Country (2021-2026)6.3 Europe Market Size YoY Growth by Country6.3.1 Germany DNA and RNA Extraction Kit Market Size YoY Growth (2015-2026)6.3.2 France DNA and RNA Extraction Kit Market Size YoY Growth (2015-2026)6.3.3 U.K. DNA and RNA Extraction Kit Market Size YoY Growth (2015-2026)6.3.4 Italy DNA and RNA Extraction Kit Market Size YoY Growth (2015-2026)6.3.5 Russia DNA and RNA Extraction Kit Market Size YoY Growth (2015-2026)7 Asia-Pacific DNA and RNA Extraction Kit Market Size by Country (2015-2026)7.1 Asia-Pacific Market Size Market Share by Country (2015-2020)7.1.1 Asia-Pacific DNA and RNA Extraction Kit Sales Market Share by Country (2015-2020)7.1.2 Asia-Pacific DNA and RNA Extraction Kit Revenue Market Share by Country (2015-2020)7.2 Asia-Pacific Market Size Market Share by Country (2021-2026)7.2.1 Asia-Pacific DNA and RNA Extraction Kit Sales Market Share by Country (2021-2026)7.2.2 Asia-Pacific DNA and RNA Extraction Kit Revenue Market Share by Country (2021-2026)7.3 Asia-Pacific Market Size YoY Growth by Country7.3.1 China DNA and RNA Extraction Kit Market Size YoY Growth (2015-2026)7.3.2 Japan DNA and RNA Extraction Kit Market Size YoY Growth (2015-2026)7.3.3 South Korea DNA and RNA Extraction Kit Market Size YoY Growth (2015-2026)7.3.4 India DNA and RNA Extraction Kit Market Size YoY Growth (2015-2026)7.3.5 Australia DNA and RNA Extraction Kit Market Size YoY Growth (2015-2026)7.3.6 Taiwan DNA and RNA Extraction Kit Market Size YoY Growth (2015-2026)7.3.7 Indonesia DNA and RNA Extraction Kit Market Size YoY Growth (2015-2026)7.3.8 Thailand DNA and RNA Extraction Kit Market Size YoY Growth (2015-2026)7.3.9 Malaysia DNA and RNA Extraction Kit Market Size YoY Growth (2015-2026)7.3.10 Philippines DNA and RNA Extraction Kit Market Size YoY Growth (2015-2026)7.3.11 Vietnam DNA and RNA Extraction Kit Market Size YoY Growth (2015-2026)8 Latin America DNA and RNA Extraction Kit Market Size by Country (2015-2026)8.1 Latin America Market Size Market Share by Country (2015-2020)8.1.1 Latin America DNA and RNA Extraction Kit Sales Market Share by Country (2015-2020)8.1.2 Latin America DNA and RNA Extraction Kit Revenue Market Share by Country (2015-2020)8.2 Latin America Market Size Market Share by Country (2021-2026)8.2.1 Latin America DNA and RNA Extraction Kit Sales Market Share by Country (2021-2026)8.2.2 Latin America DNA and RNA Extraction Kit Revenue Market Share by Country (2021-2026)8.3 Latin America Market Size YoY Growth by Country8.3.1 Mexico DNA and RNA Extraction Kit Market Size YoY Growth (2015-2026)8.3.2 Brazil DNA and RNA Extraction Kit Market Size YoY Growth (2015-2026)8.3.3 Argentina DNA and RNA Extraction Kit Market Size YoY Growth (2015-2026)9 Middle East and Africa DNA and RNA Extraction Kit Market Size by Country (2015-2026)9.1 Middle East and Africa Market Size Market Share by Country (2015-2020)9.1.1 Middle East and Africa DNA and RNA Extraction Kit Sales Market Share by Country (2015-2020)9.1.2 Middle East and Africa DNA and RNA Extraction Kit Revenue Market Share by Country (2015-2020)9.2 Middle East and Africa Market Size Market Share by Country (2021-2026)9.2.1 Middle East and Africa DNA and RNA Extraction Kit Sales Market Share by Country (2021-2026)9.2.2 Middle East and Africa DNA and RNA Extraction Kit Revenue Market Share by Country (2021-2026)9.3 Middle East and Africa Market Size YoY Growth by Country9.3.1 Turkey DNA and RNA Extraction Kit Market Size YoY Growth (2015-2026)9.3.2 Saudi Arabia DNA and RNA Extraction Kit Market Size YoY Growth (2015-2026)9.3.3 UAE DNA and RNA Extraction Kit Market Size YoY Growth (2015-2026)

10 Company Profiles and Key Figures in DNA and RNA Extraction Kit Business10.1 Qiagen10.1.1 Qiagen Corporation Information10.1.2 Qiagen Description, Business Overview and Total Revenue10.1.3 Qiagen DNA and RNA Extraction Kit Sales, Revenue and Gross Margin (2015-2020)10.1.4 Qiagen DNA and RNA Extraction Kit Products Offered10.1.5 Qiagen Recent Development10.2 Thermo Fisher Scientific10.2.1 Thermo Fisher Scientific Corporation Information10.2.2 Thermo Fisher Scientific Description, Business Overview and Total Revenue10.2.3 Thermo Fisher Scientific DNA and RNA Extraction Kit Sales, Revenue and Gross Margin (2015-2020)10.2.4 Qiagen DNA and RNA Extraction Kit Products Offered10.2.5 Thermo Fisher Scientific Recent Development10.3 Merck KGaA10.3.1 Merck KGaA Corporation Information10.3.2 Merck KGaA Description, Business Overview and Total Revenue10.3.3 Merck KGaA DNA and RNA Extraction Kit Sales, Revenue and Gross Margin (2015-2020)10.3.4 Merck KGaA DNA and RNA Extraction Kit Products Offered10.3.5 Merck KGaA Recent Development10.4 Roche10.4.1 Roche Corporation Information10.4.2 Roche Description, Business Overview and Total Revenue10.4.3 Roche DNA and RNA Extraction Kit Sales, Revenue and Gross Margin (2015-2020)10.4.4 Roche DNA and RNA Extraction Kit Products Offered10.4.5 Roche Recent Development10.5 Cytiva10.5.1 Cytiva Corporation Information10.5.2 Cytiva Description, Business Overview and Total Revenue10.5.3 Cytiva DNA and RNA Extraction Kit Sales, Revenue and Gross Margin (2015-2020)10.5.4 Cytiva DNA and RNA Extraction Kit Products Offered10.5.5 Cytiva Recent Development10.6 Agilent10.6.1 Agilent Corporation Information10.6.2 Agilent Description, Business Overview and Total Revenue10.6.3 Agilent DNA and RNA Extraction Kit Sales, Revenue and Gross Margin (2015-2020)10.6.4 Agilent DNA and RNA Extraction Kit Products Offered10.6.5 Agilent Recent Development10.7 Danaher10.7.1 Danaher Corporation Information10.7.2 Danaher Description, Business Overview and Total Revenue10.7.3 Danaher DNA and RNA Extraction Kit Sales, Revenue and Gross Margin (2015-2020)10.7.4 Danaher DNA and RNA Extraction Kit Products Offered10.7.5 Danaher Recent Development10.8 Promega10.8.1 Promega Corporation Information10.8.2 Promega Description, Business Overview and Total Revenue10.8.3 Promega DNA and RNA Extraction Kit Sales, Revenue and Gross Margin (2015-2020)10.8.4 Promega DNA and RNA Extraction Kit Products Offered10.8.5 Promega Recent Development10.9 Bio-Rad10.9.1 Bio-Rad Corporation Information10.9.2 Bio-Rad Description, Business Overview and Total Revenue10.9.3 Bio-Rad DNA and RNA Extraction Kit Sales, Revenue and Gross Margin (2015-2020)10.9.4 Bio-Rad DNA and RNA Extraction Kit Products Offered10.9.5 Bio-Rad Recent Development10.10 Bioneer10.10.1 Company Basic Information, Manufacturing Base and Competitors10.10.2 DNA and RNA Extraction Kit Product Category, Application and Specification10.10.3 Bioneer DNA and RNA Extraction Kit Sales, Revenue, Price and Gross Margin (2015-2020)10.10.4 Main Business Overview10.10.5 Bioneer Recent Development10.11 Akonni Biosystems10.11.1 Akonni Biosystems Corporation Information10.11.2 Akonni Biosystems Description, Business Overview and Total Revenue10.11.3 Akonni Biosystems DNA and RNA Extraction Kit Sales, Revenue and Gross Margin (2015-2020)10.11.4 Akonni Biosystems DNA and RNA Extraction Kit Products Offered10.11.5 Akonni Biosystems Recent Development

11 DNA and RNA Extraction Kit Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis11.1 DNA and RNA Extraction Kit Key Raw Materials11.1.1 Key Raw Materials11.1.2 Key Raw Materials Price11.1.3 Raw Materials Key Suppliers11.2 Manufacturing Cost Structure11.2.1 Raw Materials11.2.2 Labor Cost11.2.3 Manufacturing Expenses11.3 DNA and RNA Extraction Kit Industrial Chain Analysis11.4 Market Opportunities, Challenges, Risks and Influences Factors Analysis11.4.1 Industry Trends11.4.2 Market Drivers11.4.3 Market Challenges11.4.4 Porters Five Forces Analysis

12 Market Strategy Analysis, Distributors12.1 Sales Channel12.2 Distributors12.3 Downstream Customers

13 Research Findings and Conclusion

14 Appendix14.1 Methodology/Research Approach14.1.1 Research Programs/Design14.1.2 Market Size Estimation14.1.3 Market Breakdown and Data Triangulation14.2 Data Source14.2.1 Secondary Sources14.2.2 Primary Sources14.3 Author Details14.4 Disclaimer

About Us:

QY Research established in 2007, focus on custom research, management consulting, IPO consulting, industry chain research, data base and seminar services. The company owned a large basic data base (such as National Bureau of statistics database, Customs import and export database, Industry Association Database etc), experts resources (included energy automotive chemical medical ICT consumer goods etc.

More:
DNA and RNA Extraction Kit Market 2020 Increasing Demand, Growth Analysis and Future Outlook by 2026 | Qiagen, Thermo Fisher Scientific, Merck KGaA -...

A lot has been said and speculated about actor Sanjay Dutt's health ever since the Sadak 2 star earlier tweeted he will be taking a short medical break before resuming work.

While a section of the media has reported that Dutt is terminally ill and has been diagnosed with advanced-stage lung cancer, Torbaaz producer and a close friend of Sanjay Dutt, Rahul Mittra, has rubbished the rumours saying that tests are on. He added the disease and stage of the disease are yet to be ascertained.

"I have said categorically that tests are going on. I rubbish all the reports stating that it is the third stage or fourth stage. There is an ailment. What ailment is it and what stage is it, will be confirmed when all the tests are done," said Rahul Mittra in an exclusive chat with DNA.

"Sanju has time and again shared all the updates with his fans. No one has the right to speculate on the stage of the ailment, it is for the person going through it to confirm or his doctor or family members," he added.

Rahul told DNA India that we must all give the actor some time and rather than jumping to conclusions, wish him luck for a speedy recovery.

"He is a warrior, he is going to come back," said Rahul on being asked if Sanjay Dutt will be around during the world premiere of Torbaaz on streaming platform Netflix.

Torbaaz, one of Sanjay Dutt's s upcoming films, is scheduled for a digital release on the OTT platform. It's the date of release, however, is yet to be announced.

Last month, Sanjay Dutt took to his Twitter account to share his first look from the film. He wrote, A man rises from personal tragedy to lead a group of children from a refugee camp to victory, transforming their lives through the game of cricket. Its almost time to play (sic)!

Talking about the film, producer Rahul Mittra said, "It is a very special and beautiful film. It is about how Sanju will transform the lives of these kids by way of cricket."

Voicing his opinion on the transition of films being released on digital platforms rather than getting the usual theatrical release due to the coronavirus pandemic and how he as a producer sees it, Rahul said, "I am very happy that it happened and it specifically has to do with the film we have made."

He added, "Since it is a film that caters to a subject that in-between attracts international relations and world issues, so it is very relevant to the world. We are talking about the Taliban, Afghanistan, about cricket and transforming lives. So, I think no other platform could have been better."

See original here:
DNA Exclusive: 'Sanjay Dutt is a warrior, will make a comeback': 'Torbaaz' producer on the actor's health - DNA India

New Delhi, August 25

When the National Investigation Agency (NIA) began its probe into the Pulwama terror attack in which 40 CRPF personnel were killed last year, it faced a blind case in the absence of any solid proof against the perpetrators.

The case posed unique challenges, such as a lot of evidence having blown to pieces in the suicide attack and seven accused being subsequently killed in encounters. However, the central agency used forensic tests, including DNA profiling of the meagre evidence, to breach the dead ends.

It was a blind case for us. There were a lot of murmurs but everything needs to be established beyond doubt in the court of law, a senior official, who was part of the probe, said.

The first challenge was to establish the ownership of the car used by Adil Ahmad Dar, the suicide bomber, according to the chargesheet in the case filed by the NIA in a special court in Jammu on Tuesday.

There was nothing available from the vehicle which carried a cocktail of 200 kg of high-grade explosives RDX, Calcium-Ammonium Nitrate, Gelatin Sticks and Aluminium Powder.

As per the chargesheet, with the help of forensic methods and painstaking investigations the serial number of the car that was blown into pieces beyond recognition was extracted and within no time the ownership of the vehicle was establishedfrom the first to the last owner.

However, the last owner of the car, Sajjad Bhat (named in the chargesheet) of Bijbehara in Anantnag district, had disappeared hours before the February 14, 2019 attack and joined Jaish-e-Mohammed. He was subsequently killed in an encounter in June last year.

While it was clear that the suicide attacker was Adil Ahmed Dar but the same had to be established with evidence. After picking up human remains from various spots, they were sent for DNA profiling, the official, who requested anonymity, said.

The suicide attacker was identified and confirmed by matching the DNA extracted from the meagre car fragments with that of the DNA of his father, he said.

Moreover, seven accused wanted in the case by the NIA were killed during different encounters in 2019.

The chargesheet has named Mohammed Umar Farooq, the nephew of Jaish-e-Mohammed chief Masood Azhar, as the main conspirator of the suicide mission. According to officials, Farooq had infiltrated into India in April 2018 and was subsequently killed in one of the encounters in South Kashmir last year. Officials said the role of conspirators which included Mudasir Ahmed Khan, Qari Mufti Yasser and Mohd Kamran came to light but all of them were killed in different encounters with security forces.

Khan was killed on March 10, Kamran on March 29, Sajjad Bhat on June 18 of last year while Qari Yasser was shot in an encounter on January 25 this year.

A team led by joint director of the NIA Anil Shukla gathered evidences and statements of terrorists and their sympathisers arrested in different cases in order to expose the conspiracy hatched for executing the audacious attack on the para-military convoy, officials said.

After JeM spokesperson Mohd Hassan in a video claimed that his group was responsible for the attack, it was sent for forensic examination and the Internet Protocol address was traced to a computer based in Pakistan.

A lot of digital, forensic, documentary and oral evidence establishing a fool-proof case against the accused for this dastardly and barbaric attack has been collected, NIA Deputy Inspector General and spokesperson Sonia Narang said. The charge-sheet has brought on record the all-out involvement of Pakistan-based entities to carry out terrorist strikes in India and to incite and provoke Kashmiri youth, she said.

Culminating its 18-month long probe into the fatal terror attack that left 40 CRPF personnel dead in South Kashmir last year, the NIA on Tuesday filed a chargesheet in a special court in Jammu against 19 people including Masood Azhar, the chief of banned terror group Jaish-e-Mohammed, for planning the suicide operation.

Giving details of the 13,500-page chargesheet, Narang said the chargesheet marks the culmination of a year-and-a-half long painstaking and meticulous investigation with valuable inputs received from other central and state government agencies as well as foreign law-enforcement agencies. PTI

More:
Pulwama probe: NIA used DNA, other forensic tests to trace evidence that had blown to pieces - The Tribune India

Hillary Clinton has a piece of advice for Democratic presidential candidate Joe Biden: Whatever happens, do not concede defeat on the night of the Nov. 3 election.

Clinton, a Democrat, lost the 2016 presidential election to President Donald Trump, a Republican whose re-election bid is facing a stiff challenge from Biden, who has been leading Trump in public opinion polls.

Clinton conceded defeat on the night of the election in 2016 but said the shift to mail-in voting due to the coronavirus pandemic means it could take longer to know the winner in November.

She said this year`s election day results might point to Trump having a narrow advantage. But in that case, Clinton said, "Joe Biden should not concede under any circumstances because I think this is going to drag out."

Clinton, a former U.S. secretary of state, was speaking an interview on Showtime`s "The Circus," a portion of which was released on Tuesday.

A Biden campaign spokesman declined to comment.

As many as half of U.S. voters are expected to cast their votes by mail this year, more than twice as many as in 2016, but not all state and local officials have the capacity to count mail ballots as quickly as those cast in person.

Also, some states, including battlegrounds like Ohio and North Carolina, allow ballots to count if they arrive days after polls close but are postmarked by election day.

"Eventually I do believe he will win if we don`t give an inch and if we are as focused and relentless as the other side is," Clinton said.

Trump has without citing evidence criticized mail voting as rife with fraud, although he has requested a mail ballot for his own use in this year`s election.

Trump, who is due on Thursday to formally accept his party`s nomination for the election, has also criticized mail voting because it might slow down vote counting.

Read more:
'Whatever happens, do not concede defeat on election night': Hillary Clinton to Joe Biden - DNA India

American actor Jennifer Garner on Monday local time shared a dramatic video of her emotional reaction to finishing watching The Office series.

The 48-year-old star shared on Instagram a slow-motion, dramatically shedding a tear sort of video right after completing all the nine seasons of the hit show.

Captioning the video, she wrote: "My kids and I have spent months piled on the couch working our way through 'How to Behave as Grownups', aka #TheOffice. Apparently, we are sensitive people, the finale hit us pretty hard. When I realized I'd accidentally shot my farewell testimonial in slo-mo I realized: your Monday might need this, too."

Sported in a Dunder Mifflin (fictional paper sales company featured in the show) printed T-shirt, Garner narrated the video, saying, "You'll never guess which show my kids and I watched an episode a day off through quarantine and guess what? We finished it, and guess what? It gave me some really big feelings."

"Look who needed a big cry and maybe a shower would have been helpful, but it's just nice to know you can still just feel so much passionate about something, right? So thank you. If you've ever heard of the show, The Office, you should try it. It's wonderful," the Daredevil actor added.

on Aug 24, 2020 at 4:12pm PDT

Angela Kinsey, who played one of the leading roles commented on Jennifer's post. She wrote, "Omg!! @jennifer.garner I am only just seeing this (we had no air conditioning for the day so long story short but Im only just catching up on things)!! I love this. I love you and your family and just so you know the finale makes me bawl my eyes out too!"

While Jenna Fischer commented, "Oh Lady!! This is the sweetest and most wonderful post!! Sending you lots of love and if you want to start over @angelakinsey and I are re-watching for the podcast. We are in the middle of Season 3 and have major feelings about lots of moments (Art Show, Dwight comforting Pam...)"

The American sitcom, which depicts the everyday work lives of office employees, was aired on NBC from 2005 to 2013.

The mockumentary had Steve Carell, Rainn Wilson, John Krasinski, Jenna Fischer, Mindy Kaling, B. J. Novak, Ed Helms, Mindy Kaling, Craig Robinson, James Spader, Ellie Kemper and Catherine Tate in the lead roles.

Excerpt from:
Jennifer Garners emotional video on watching 'The Office' finale gets sweet responses from the cast - DNA India

James Anderson achieved history in the third and final Test against Pakistan in Southampton as he became the first pacer in history to take 600 wickets. Anderson achieved the feat when he dismissed Pakistan opposition skipper Azhar Ali to enter a club of greats. Only Muttiah Muralitharan, Shane Warne and Anil Kumble are ahead of him but as a fast bowler, he now stands alone on top. However, James Anderson is best remembered for his ability to come out on top in battles against the top opposition batsmen in his era. The list has some very prestigious names. The fact that Anderson has gotten the better of them consistently is an even bigger tribute to his greatness.

If one looks at the summary of batsmen dismissed, Anderson has gotten the better of Australia skipper Michael Clarke nine times in 26 Ashes Tests as well as David Warner the same number of times. It is no surprise that Australians dominate the list as England play frequently in the Ashes. However, there are two names which are there on the list for the most number of dismissals. Those names add credence to his magnificent career.

Sachin Tendulkar, Kumar Sangakkara and Jacques Kallis have a combined total of over 40,000 Test runs. These three batsmen dominated the Test scene from the start of the millennium upto their retirement in the middle of the second decade. However, there is one common factor linking all these three greats and that is their dismissals to Anderson.

Sachin Tendulkar has fallen to James Anderson nine times in his career. This is the most he has fallen to any bowler in Tests. Tendulkar was dismissed by Anderson in the 2006 Mumbai Test. In the 2007 series against England, Anderson dismissed Tendulkar at Lords and then twice at the Oval. In 2008, Tendulkar fell to Anderson in the Mohali Test while in 2011, Anderson was on top in Lords and Trent Bridge.

In 2012, Anderson continued his dominance when he dismissed Tendulkar in the Kolkata Test and in Nagpur. Even in the case of Kumar Sangakkara, he dismissed him three times in Sri Lanka and four times in England. For Jacques Kallis, Anderson has achieved more success in England than in South Africa. Anderson is level with Shane Warne for dismissing one of the finest ever in world cricket.

There are other great batsmen in the current era whom Anderson has dismissed. The right-arm pacer has gotten rid of Virat Kohli five times, Steve Smith and Kane Williamson have also fallen prey to him many times although Smith has a better average against Anderson. The ability of Anderson to dismiss the top player in the opposition truly makes him a stand-out.

Go here to see the original:
James Anderson 600 Test wickets: Coming out on top vs Sachin Tendulkar and Jacques Kallis - DNA India

James Anderson created history by becoming the first pacer in Test history to take 600 wickets. Anderson achieved the landmark when he got the Pakistan skipper Azhar Ali out on the final day of the third Test between England and Pakistan at the Rose Bowl in Southampton. At 38 years, age is not on James Andersons side. With the England Test schedule uncertain, it could be a long time before Anderson is seen in white clothing again. There have been plenty of speculations that Anderson might announce his retirement from Test cricket and it would bring an end to a magnificent 17-year career where he has transformed Englands bowling fortunes along with Stuart Broad.

However, speaking after the end of the match, Anderson has brushed aside any speculation that he might retire and instead, he wants to focus on the 2021 Ashes as well as reaching yet another magical landmark of 700 wickets.

In this Test, I was really on it and I feel like I've still got stuff to offer this team. I don't think I've won my last Test matches as an England cricketer yet. Can I reach 700? Why not? I still love turning up every day at training, putting in the hard yards and being in the dressing room with the lads trying to forge a win for England. That's all I've really ever bothered about and what I'll keep trying to do, Anderson said.

The point was echoed by skipper Joe Root during the post-match presentation. To be able to stand up and perform in Test cricket over such a long period of time is a fantastic achievement. Credit to him. Absolutely see Broad and Anderson continuing for a long time for us, Root said.

Like Tendulkar in batting

Before James Anderson, Australia pacer Glenn McGrath had held the record for the most wickets by a pace bowler with 563 wickets. Anderson broke McGraths record in 2018 against India at The Oval while in 2020, he has managed to reach the magical figure of 600 wickets.

McGrath has said that just like how Sachin Tendulkar set the bar for Test cricket with his batting, Anderson has set the gold standard when it comes to pace bowling.

No one is ever going to catch Sachin in Test cricket for the amount of runs he's scored (15,921) and the matches he's played (200). Jimmy's done the same for fast bowling. I didn't have the skill level Jimmy has. When he's swinging that ball, both ways, in control, there's no one better, McGrath said.

Read more from the original source:
Can I reach 700? Why not? James Anderson insists he is far from done - DNA India

When Truth is All You Have

By Jim McCloskey with Philip Lerman

Doubleday. 300 pp. $26.95

- - -

In early 1979, Jim McCloskey was in his mid-30s, safely home from Vietnam and settling into a successful career as a consultant. Yet his life felt emotionally empty, so he turned to romance, dividing his time between a not-yet-divorced woman and a Times Square prostitute named Brandy whom he genuinely adored.

Worried that his personal life was "reaching rock bottom," he returned to his Presbyterian church and began studying the Bible. But Augustine's prayer comes to mind: "Lord, make me chaste, but not yet" McCloskey ventured into Times Square again and, Brandy being unavailable, picked up another woman, only to awaken later to find his wallet gone.

"That was the moment I got up, looked in the mirror, and finally said to myself, what the hell way is this to live your life?"

From this salty beginning, the modern innocence movement was born.

Nearly a decade before the Innocence Project freed a single prisoner, and five years before Errol Morris produced "The Thin Blue Line," McCloskey exonerated his first inmate and launched the nation's first organization devoted to reinvestigating wrongful convictions.

In the 37 years since he founded Centurion Ministries, McCloskey has won the exonerations of 63 men and women two on death row within days of execution, others imprisoned for decades, adding up to 1,330 years spent paying for crimes they didn't commit.

The reason you may not have heard of McCloskey or Centurion Ministries, as you probably have Barry Scheck, Peter Neufeld and the Innocence Project, is that Centurion takes on the cases with no DNA, the hardest ones that require years of knocking on doors and poring over documents without biological evidence to score an easy home run. McCloskey is Paul Drake in a world of CSI, a gumshoe investigator without a lab.

"When Truth Is All You Have," a memoir of McCloskey's life and work, is a riveting and infuriating examination of criminal prosecutions, revealing how easy it is to convict the wrong person and how nearly impossible it is to undo the error. It upends our naive and complacent view of prosecutions or at least White views, since minorities have long had no such illusions and demonstrates, case by case, what "a cruel, mindless, mean machine the justice system can be."

It is also a story of faith, in which McCloskey's belief in the legal system, and in God, is put on trial and often found wanting.

In the fall of 1980, McCloskey was beginning his second year at Princeton Theological Seminary when he began serving as student chaplain at Trenton State Prison. It housed the most dangerous criminals in New Jersey, including Jorge de los Santos, an admitted heroin addict who had been convicted of murder. The inmate insisted that he was framed for the crime and finally persuaded McCloskey to read the trial transcript during his Thanksgiving holiday. When McCloskey returned after the break, he told de los Santos that he believed he might be innocent.

"What are you going to do about it?" de los Santos asked. "Are you just going to go back to your nice little safe seminary and pray for me? . . . I need someone to free me from this hell on earth. Whether you like it or not, you are that man."

McCloskey put seminary on hold and spent the next year reinvestigating. He discovered that the state's case relied on a drug addict and a jailhouse informant, and that the informant had lied on the stand with the knowledge of the prosecutor. McCloskey found a lawyer to bring the case to trial, and in July 1983, Jorge de los Santos walked out of prison, exonerated.

By this point McCloskey had earned his master's of divinity, and he had to choose between the pulpit and the prisoners. He chose the prisoners. He was floored and outraged at the corruption he found in the criminal justice system. But he also felt alive, called to a divine adventure.

"I was living a film noir life," he recalls. "I was Humphrey Bogart, tracking down the Maltese Falcon; I was Philip Marlowe and Sam Spade all wrapped up in one."

It wasn't all glamour, as he pored over musty documents with a glass of bourbon in one hand and a yellow highlighter in another, but he had found his purpose. With a $10,000 gift from his parents, he launched his organization from his bedroom in Princeton. He called it Centurion Ministries, reminiscent of the Roman centurion in the Book of Luke who looks up at Jesus hanging on the cross and says, "Surely, this one was innocent."

For the first time in his life, McCloskey knew his purpose: to free innocent people in prison.

"I believed this was destiny, that this was why God put me on earth. That everything that came before, all the ups and downs in my life, was in preparation for this work."

And he was good at it. The unlikeliest people talked to him: jailhouse informants, perjured or frightened witnesses and their families, friends of the actual perpetrators, detectives with doubts, immigration officials.

"This friendly, paunchy guy with a sense of humor and a smile on his face walks up with his little clerical collar on, and people just naturally let their guard down," he writes with some amazement. He listened without judgment, and these conversations became confessionals as he helped people "release the guilt of hiding a lie year after year after year."

Early on, McCloskey attracted the attention of the New York Times and "60 Minutes" when his investigation exonerated Nate Walker, who was serving a life sentence for allegedly raping a white woman. Within days of the "60 Minutes" episode, hundreds of letters poured through McCloskey's mail slot from convicted rapists and murderers, forcing him (and later his small band of staff and volunteers) to decide who deserves a second chance and who does not. It was a Godlike role, deciding life and death.

The responsibility weighed on McCloskey, and it reveals one of the most disturbing aspects of the innocence movement: the sheer randomness of it. How many innocent people are serving time but can't attract the attention of overwhelmed investigators like McCloskey and his staff? What if no DNA was found at the crime scene, putting their cases largely off limits to the Innocence Project? For that matter, how many cases pique the interest of local or national news media, pressuring the courts to reconsider the verdict? There are far more innocent prisoners than investigators, and McCloskey believes tens of thousands of them languish in prison.

The details of each story in the memoir differ, but the themes are the same. Jailhouse informants who have incentive to lie for the prosecution often play starring roles at trial. Witnesses are intimidated into giving false testimony. Innocent people confess after hours of questioning. Forensic evidence other than DNA ballistics, bite marks, hair analysis is often about as accurate as flipping a coin.

Prosecutors hide evidence and put lying witnesses on the stand. Police develop tunnel vision, become obsessed with one suspect and ignore exculpatory evidence.

"Once some poor innocent soul is singled out, and law enforcement is convinced of his guilt, the train has left the station," McCloskey writes. "There is no turning back. Truth has been left behind."

Read more:
Taking on the hardest cases without DNA and setting the innocent free - theday.com

Thursday's Access Utah episode.

You swab your cheek or spit into a vial, then send it away to a lab somewhere. Weeks later you get a report that might tell you where your ancestors came from or if you carry certain genetic risks. Or the report could reveal a long-buried family secret and upend your entire sense of identity.

In The Lost Family: How DNA Testing is Upending Who We Are, journalistLibby Copelandinvestigates what happens when we embark on a vast social experiment with little understanding of the ramifications. Copeland explores the culture of genealogy buffs, the science of DNA, and the business of companies like Ancestry and 23andMe, all while tracing the story of one woman, her unusual results, and a relentless methodical drive for answers that becomes a thoroughly modern genetic detective story.

Libby Copeland is an award-winning journalist and author who writes from New York about culture, science, and human behavior. As a freelance journalist, she writes for such media outlets as The Atlantic, Slate, New York, Smithsonian, The New York Times, The New Republic, Esquire.com, The Wall Street Journal, Fast Company, and Glamour.

A graduate of the University of Pennsylvania, she was a 2010 media fellow at Stanford Universitys Hoover Institution. Her article for Esquire.com, Kates Still Here, won Hearst Magazines 2017 Editorial Excellence Award for reported feature or profile. She previously won first prize in the feature specialty category from the Society for Features Journalism (then called AASFE). She lives in Westchester, NY, with her husband and two children.

Read the rest here:
Revisiting Genealogy And DNA Testing With Libby Copeland On Thursday's Access Utah - Utah Public Radio

Earth is the only planet (and the only body in the universe) we can be certain life exists on, if you count out that accidental tardigrade spill on the Moon. That doesn't necessarily mean we are a cosmic anomaly. If there is life on other planets, there may be a way to find out how it could have evolved before it is ever even found.

Astrobiologist Betl Kaar realized figuring out how the machinery of life works means that you have to work backwards. She decided to break it by using ancestral sequencing to find out how evolution shaped organisms here on Earth and could shape alien life-forms. She has now found that the process of evolution is surprisingly terrible at multitasking. It just handles the most immediate problem, then moves to the next one without having finished its work on the previous one. Cells dont resolve issues like we do, which gives us a glimpse at how evolution and natural selection happen on Earth and could occur on other planets.

In rapidly evolving populations, natural selection may not be able to improve all modules simultaneously because adaptive mutations in different modules compete against each other, Kaar said in a study she led, which was recently published in PNAS, adding that adaptation in some modules would stall, despite the availability of beneficial mutations.

Cellular modules are molecules that interact to carry out functions within the cell, such as signal transmission and metabolic functions. Translation machinery (TM) is a complex metabolic pathway that creates proteins from information encoded in cells, influencing how living things evolve. It morphs information into proteins that become parts of molecules which can actually do things for the cell and the organism. Kaar and her team studied what happened when E.coli cells were evolutionarily undone and then had to re-evolve. Enter ancestral sequencing. She genetically engineered the microbes with ancient evolutionary proteins going back as far as 700 million years.

No, this doesnt mean that resurrecting ancient life-forms Jurassic Park style is actually possible. That would take much more than just a single cell, and much of the dinosaur DNA that has been preserved has broken over the millennia and is too far gone to pull something like that off, though maybe the movie'sMr. DNA (pictured) would disagree.

Translation machinery itself is basically a living fossil. It is thought to have been around for over 3.5 billion years of evolution, but despite that, it obviously never learned how to perfect itself. Kaar wanted to twist and finally break TM to see how the cells would evolve in response. In the beginning, it seemed that improvements in the warped TM were evidence of natural selection doing what it was expected to do. That didnt last. Before the cells could fully evolve a solution to restore their broken translational machinery, other cellular modules took precedence. Mutations appeared randomly. Natural selection was supposed to result in the squashing of those mutations, but instead, the process was just as random, though it did lean towards mutations that gave the E.Coli bacteria the best chance at survival.

Cellular modules may not be fully optimized by natural selection despite the availability of adaptive mutations, said Kaar.If environmental fluctuations are sufficiently frequentsome modules may remain stalled for long periods of time despite being improvable, at least in the absence of recombination.

Evolutionary stalling has been theorized before, but this is the first time it has ever been proven. The process of evolution can really only handle one thing at a time, and that one thing is the problem that is first to get its attention at the expense of every other issue. Other positive mutations would have seen advancement if the evolutionary process was able to multitask, but those are left behind in what Kaar and her colleagues call evolutionary stalling.The only way to at least somewhat resolve this is the internal exchange of genetic material otherwise known as recombination. This phenomenon happens when that material is transferred between multiple chromosomes or regions of the same chromosome, but she wanted to observe what ended up happening to the E.Coli without it.

Kaar is not stopping there. For her, the ultimate experiment would be breaking down life to its prebiotic origins and then putting it back together to see how life first formed on Earth and could have possibly emerged elsewhere in the cosmos. Now we can only wait to see what Perseverance unearths on Mars.

Follow this link:
DNA nearly a billion years old is being warped to figure out how life could evolve on other planets - SYFY WIRE